![Mary Thistle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
Mary T.
Thistle is currently Director at Cocoon Biotech, Inc. She is Independent Director at Cullinan Therapeutics, Inc. since 2024, Q32 Bio, Inc. since 2018, Enterome SA since 2017, Entrada Therapeutics, Inc. since 2021, and Aktis Oncology, Inc. starting in 2025.
Former roles include Independent Director at Alaunos Therapeutics, Inc. from 2020 to 2023, Vigil Neuroscience, Inc. from 2022 to 2025, and Homology Medicines, Inc. Senior Vice President-Business Development at Cubist Pharmaceuticals LLC from 2014 to 2015, ViaCell, Inc., and PerkinElmer U.S.
LLC from 2007 to 2008.
Chief Financial & Accounting Officer at Dimension Therapeutics, Inc. in 2017.
Special Advisor at Bill & Melinda Gates Medical Research Institute from 2020 to 2022.
Accountant at Deloitte & Touche LLP.
Principal at Sierra Research & Technology, Inc. Consultant at Yoshida & Sokolski PC.
Education includes an undergraduate degree from the University of Massachusetts, conferred in 1983.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
-.--% | 12/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 04/05/2021 |
| CULLINAN THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/08/2024 |
| AKTIS ONCOLOGY, INC. | Direttore/Membro del Consiglio | 01/01/2025 |
Cocoon Biotech, Inc.
 Cocoon Biotech, Inc. BiotechnologyHealth Technology Develops and manufactures medicines for osteoarthritis patients | Direttore/Membro del Consiglio | - |
Enterome SA
 Enterome SA Pharmaceuticals: MajorHealth Technology Develops immunomodulatory drugs for treatment of cancer | Direttore/Membro del Consiglio | 01/01/2017 |
| Società | Posizione | Fine |
|---|---|---|
| VIGIL NEUROSCIENCE, INC. | Direttore/Membro del Consiglio | 05/08/2025 |
| ALAUNOS THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 18/12/2023 |
Bill & Melinda Gates Medical Research Institute
 Bill & Melinda Gates Medical Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization dedicated to the development of novel biomedical interventions | Ufficiale delle Risorse Umane | 01/10/2020 |
| DIMENSION THERAPEUTICS INC | Direttore Finanziario/CFO | 01/12/2017 |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 17 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology Provides and develops cellular medicine for the treatment of diseases | Health Technology |
Cocoon Biotech, Inc.
Cocoon Biotech, Inc. BiotechnologyHealth Technology Develops and manufactures medicines for osteoarthritis patients | Health Technology |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Sierra Research & Technology, Inc.
 Sierra Research & Technology, Inc. Information Technology ServicesTechnology Services Designs intellectual property and cores for the high speed networking and display driver markets | Technology Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Develops immunomodulatory drugs for treatment of cancer | Health Technology |
Yoshida & Sokolski PC
 Yoshida & Sokolski PC Miscellaneous Commercial ServicesCommercial Services Operates as a certified public accounting firm | Commercial Services |
PerkinElmer U.S. LLC
 PerkinElmer U.S. LLC BiotechnologyHealth Technology Develops diverse analytical equipment and applications on chemicals, reagents, standards, media and disposable labware | Health Technology |
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for rare diseases | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
Entrada Therapeutics, Inc.
 Entrada Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for rare neuromuscular diseases | Health Technology |
Bill & Melinda Gates Medical Research Institute
Bill & Melinda Gates Medical Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization dedicated to the development of novel biomedical interventions | Commercial Services |
Vigil Neuroscience, Inc.
 Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
Cullinan Oncology, Inc.
 Cullinan Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers radiopharmaceuticals to treat tumor cancers | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
